Stock screenerAll disclosures →
EDGAR →
DGX
Conviction 51HealthcareScan · Thu, Jun 25, 2026DGX$206.41+1.62%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 950.81K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price206.41
Change+1.62%
Gap-0.10%
Rel volume1.21×
Avg volume895.07K
Avg $ vol178.15M
SMA 20198.76
SMA 50195.34
SMA 200189.95
Price vs 50+5.67%
Price vs 200+8.66%
MA stackbullish
50/200 cross—
Supertrendup · 191.12
RSI (14)63
MACD hist0.25
MACD crossbull · 0d
Stoch %K / %D90 / 64
ADX (14)20
+DI / −DI33 / 15
RSI divergence—
MACD divergence—
ATR %+2.27%
ADR %2.22%
52w high211.91
52w low166.42
From 52w high-2.60%
Above 52w low+24.03%
New 52w highNo
SqueezeOff
Bollinger width8.71%
%B0.94
Donchian pos90.69%
Donchian high207.99
Donchian low191.02
AVWAP (52w high)197.14
vs AVWAP high+4.70%
AVWAP (52w low)187.32
vs AVWAP low+10.19%
OBV trendFlat
Chaikin MF (20)-0.09
Today vs 20d1.21×
Avg vol (14d)950.81K
Avg vol (20d)895.07K
Avg $ vol (20d)178.15M
Market cap22.85B
RS 3m (vs SPY)-8.67%
RS 6m (vs SPY)+7.63%
RS line new highNo
Trend template6/8
Technical rank77.5
1 week+4.37%
1 month+7.01%
3 months+5.06%
6 months+17.05%
1 year+14.74%
YTD+18.77%
P/E23.03
P/B3.10
P/S2.07
P/FCF16.81
EPS8.75
Div yield1.54%
ROE13.47%
ROA5.95%
Debt/Eq0.77
Current1.18
EV/EBITDA13.23
Gross margin32.92%
Net margin8.99%
Rev growth11.78%
EPS growth13.89%
Price target223.13
Target upside8.10%
Analyst ratingBuy
Institutional107.44%
Ent. value28.13B
Revenue2.9B
Net income252M
Gross profit—
Free cash flow1.36B
IndustrySERVICES-MEDICAL LABORATORIES
ExchangeNYSE
Shares out110.7M
Employees57K
ListedTue, Dec 17, 1996
Free float109.45M
Float %99.6%
Short interest3.43M
Days to cover4.2d
Short volume63.0%
Squeeze score46 / 100
Next earningsThu, Jul 23, 2026 · pre-mkt (28d)
EPS forecast$2.81 · 9 est
Last EPS vs est$2.50 vs $2.37
Last surprise+5.5% beat
Setup gradeC
Conviction51 / 100
Pattern quality—
Tech rank77.5 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance202.44
Support186.33
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in DGX · 3 recent
Insider activity
SEC Form 4 transactions in DGX · 5 buys · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
KUPPUSAMY KARTHIK SVP, Clinical Solutions · Common Stock · 2026-06-04 | Sell | 8.15K | $1.6M | 2026-06-04 | 2026-06-08 |
KUPPUSAMY KARTHIK SVP, Clinical Solutions · Common Stock · 2026-06-04 | Exercise | 3.32K | $424K | 2026-06-04 | 2026-06-08 |
KUPPUSAMY KARTHIK SVP, Clinical Solutions · Common Stock · 2026-06-04 | Other | — | — | 2026-06-04 | 2026-06-08 |
KUPPUSAMY KARTHIK SVP, Clinical Solutions · Non-Qualifed Stock Option (right to buy) · 2026-06-04 | Exercise | 4.83K | $588K | 2026-06-04 | 2026-06-08 |
KUPPUSAMY KARTHIK SVP, Clinical Solutions · Non-Qualifed Stock Option (right to buy) · 2026-06-04 | Exercise | 3.32K | $424K | 2026-06-04 | 2026-06-08 |
KUPPUSAMY KARTHIK SVP, Clinical Solutions · Common Stock · 2026-06-04 | Exercise | 4.83K | $588K | 2026-06-04 | 2026-06-08 |
Davis J. E. CEO and President · Common Stock · 2026-06-01 | Sell | 10K | $1.9M | 2026-06-01 | 2026-06-02 |
Gregg Vicky B Director · Common Stock · 2026-05-20 | Grant | 1.14K | $0 | 2026-05-20 | 2026-05-21 |
Diaz Luis Director · Common Stock · 2026-05-20 | Grant | 1.14K | $0 | 2026-05-20 | 2026-05-21 |
Doi Tracey Director · Common Stock · 2026-05-20 | Grant | 1.14K | $0 | 2026-05-20 | 2026-05-21 |
SEC filings
EDGAR filings in DGX · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.